媒體:
221
建立:
2019/05/02
管理者:
系統管理者, TUA秘書處, TUA會計採購組, TUA人資客服組, TUA學術會議組, TUA學術資訊組
  1. 知識庫
  2. ...
  3. 2019年會
  4. 摘要
  5. 媒體
管理者：系統管理者, TUA秘書處, TUA會計採購組, TUA人資客服組, TUA學術會議組, TUA學術資訊組
  1. 1.
    Non-Discussion Poster
    1. 1.1
      NDP01: Reconstruction of scrotal and urethral defects in a case of fournier gangrene with gracilis muscle flap and buccal mucosa graft
    2. 1.2
      NDP02: Primary small cell neuroendocrine carcinoma (SCNEC) of the seminal vesicle: a case report
    3. 1.3
      NDP03: Epispadias with chordee: a single surgical experience
    4. 1.4
      NDP04: Management of neourethral stricture using Allium urethral stent: Taiwan first case report
    5. 1.5
      NDP05: Transureteroureterostomy long-term surgical outcome - a single institute experirence
    6. 1.6
      NDP06: Case report: malignant mesothelioma of tunica vaginalis testis with no obvious associated documented risk factors except exposure to corn powder
    7. 1.7
      NDP07: Robotic-assisted retropubic urethrolysis for colposuspension related bladder neck obstruction-a case report
    8. 1.8
      NDP08: Elective radical prostatectomy for huge prostate cancer with bilateral obstructive uropathy、rectal invasion and oligometastasis of bone
    9. 1.9
      NDP09: Severe dysgeusia - loss of taste of spicy, a rare adverse effect of enzalutamide: first case report in Taiwan
    10. 1.10
      NDP10: Retroperitoneal mature cystic teratoma in a young woman: a rare case report
    11. 1.11
      NDP11: Solitary fibrous tumor of urinary bladder – a case report
    12. 1.12
      NDP12: Highly selective arterial embolization with dye and gelfoam before partial nephrectomy, preliminary report
    13. 1.13
      NDP13: Case report: a case of penile root schwannoma
    14. 1.14
      NDP14: Malignant leydig cell tumor with intraperitoneal carcinomatosis
    15. 1.15
      NDP15: Pubovaginal sling erosion to vagina and bladder complicated with sling stone in vesicovaginal fistula – a very rare case report
    16. 1.16
      NDP16: Case report: the clinical features and management of complete androgen insensitivity syndrome in a 16-year-old female
    17. 1.17
      NDP17: Complete remission of multiple bony-metastatic bladder cancer with Pembrolizumab
    18. 1.18
      NDP18: Schwannoma of the prostate presenting with elevated PSA level
    19. 1.19
      NDP19: Experience of robotic-assisted laparoscopic pyeloplasty for 1-year-old girl with ureteropelvic junction obstruction in Taiwan
    20. 1.20
      NDP20: A hairball in the urinary bladder: an unusual finding
    21. 1.21
      NDP21: Uretero-iliac artery fistula - a rare case report
    22. 1.22
      NDP22: Unusual findings during inguinal hernia surgery: 2 rare cases
    23. 1.23
      NDP23: Case report: prostate cancer with skin metastasis
    24. 1.24
      NDP24: Metastatic prostate cancer with osteolytic bone lesion and hypercalcemia: a case report
    25. 1.25
      NDP25: Retroperitoneal dedifferentiated liposarcoma with a compressed invasion-freekidney - a rare case report
    26. 1.26
      NDP26: Penile metastasis from recurrent fibrosarcoma in a teenager: one case report
    27. 1.27
      NDP27: Intra-urethral condyloma acuminata treated by electrocauterization --- a case report and literature review
    28. 1.28
      NDP28: A ureterocutaneous fistula after nephrectomy
    29. 1.29
      NDP29: Prostatic stromal tumor of uncertain malignant potential (STUMP) presenting with urinary obstruction: a case report and literature review
    30. 1.30
      NDP30: The benefit of resveratrol on bladder cancer
    31. 1.31
      NDP31: Case report and review of literature: solitary fibrous tumor of scrotum.
    32. 1.32
      NDP32: Spermatic cord plasma cell neoplasm misdiagnosed as inguinal hernia:a case report
    33. 1.33
      NDP33: Large scrotal tumor in a bedridden patient with tuberculosis - a rare squamous cell carcinoma case report and literature review
    34. 1.34
      NDP34: Spermatic cord abscess presented as incarcerated hernia:a rare case report
    35. 1.35
      NDP35: Duplicated kidney with ectopic ureter in a girl presented with persistent incontinence: a case report and review
    36. 1.36
      NDP36: Silmutaneous adrenal pheochromocytoma and retroperitoneal schwannoma presenting with takotsubo syndrome
    37. 1.37
      NDP37: Liposarcoma of left spermatic cord mimicking a inguinal hernia
    38. 1.38
      NDP38: Case report of surprising intravesical foreign body removal
    39. 1.39
      NDP39: Pheochromocytoma of organ of zuckerkandl: a case report and literature review
    40. 1.40
      NDP40: Paraganglioma of the urinary bladder : a rare case and literature review
    41. 1.41
      NDP41: Case report: ectopic thyroid tissue in the adrenal gland presenting as an adrenal incidentaloma
    42. 1.42
      NDP42: Laparoscopic total extraperitoneal (TEP) approach of a rare case: inguinal bladder herniation
    43. 1.43
      NDP43: Renal oncocytoma: a rare case and literature review
    44. 1.44
      NDP44: Incidentally found metastatic adenocarcinoma of prostate in an incised inguinal hernia sac
    45. 1.45
      NDP45: Case report: a case of left adrenal pseudocyst
    46. 1.46
      NDP46: Segmental renal infarction resulting from blunt abdominal trauma
    47. 1.47
      NDP47: A rare case with combined traumatic dislocation of testis and degloving injury of penile skin after motorcycle accident
    48. 1.48
      NDP48: Sliding inguinal hernia presenting with urine retention: a rare case diagnosed with imaging
    49. 1.49
      NDP49: Angiomyolipoma of the adrenal gland: a case presentation and review of the literature
    50. 1.50
      NDP50: Bronchogenic cyst mimicking an adrenal tumor: report of a rare case
    51. 1.51
      NDP51: Minimal invasive radical nephrectomy for renal cell carcinoma larger than 10cm: a single institution experience
    52. 1.52
      NDP52: Subjective symptom improvement of silodosin treatment for BPH patients with unsatisfactory response to initial α 1 blocker
    53. 1.53
      NDP53: Diagnosis and treatment of bladder hernia -report of two cases
    54. 1.54
      NDP54: Intravesical migration of a Hem-o-lok clip: a rare delayed complication five years after robotic assisted radical prostatectomy
    55. 1.55
      NDP55: Intravesical Hem-o-Lok clips migration after robot assisted radical prostatectomy – a case report
    56. 1.56
      NDP56: Unusual metastasis to lower lip of renal clear cell carcinoma: a case report
    57. 1.57
      NDP57: Urothelial papilloma growing from middle third ureter and protruding into urinary bladder in a young female
    58. 1.58
      NDP58: Entero-vesical fistulas-a nightmare of the patient: 2 case reports and review of literature
    59. 1.59
      NDP59: The expected outcome of microscope assisted vasovasostomy – a single medical center experience
    60. 1.60
      NDP60: Comparison of robot-assisted vasovasostomy and traditional microscopic vasovasostomy: a single center experience
    61. 1.61
      NDP61: Giant penis: a male with rare penile shaft subcutaneous fibrolipoma: a case report and review on literatures
    62. 1.62
      NDP62: Unusual early mechanical small bowel obstruction caused by retained staples after ileal ureter replacement---a case report
    63. 1.63
      NDP63: Simultaneous urothelial carcinoma of urinary bladder and renal cell carcinoma- one case report with literature review
    64. 1.64
      NDP64: Is renal subcapsular extravasation and urinoma formation caused by obstructive urolithiasis, iatrogenic procedure, or post.traumatic injury result?
    65. 1.65
      NDP65: Robotic surgery in urinary tract reconstruction
    66. 1.66
      NDP66: Low intensity extracorporeal shockwave therapy for erectile dysfunction: Cathy General Hospital Experience
    67. 1.67
      NDP67: UTUC in a complete duplicated collecting system - a rare case report
    68. 1.68
      NDP68: Müllerianosis of the urinary bladder: a rare case report
    69. 1.69
      NDP69: Gastric cancer with bladder metastasis after radical total gastrectomy—case repor
    70. 1.70
      NDP70: A randomised controlled trial to compare the efficacy of thulium laser enucleation versus greenlight laser vaporesection of the prostate for the treatment of benign prostatic obstruction: midterm report
    71. 1.71
      PD1-1: Predictors for biochemical failure in patients with positive surgical margin after robotic-assisted radical prostatectomy
    72. 1.72
      MP001: Using a six-color color cards system may help improve the descriptive consistency of the hematuria severity during communication with medical staffs.
    73. 1.73
      PD1-2: Prostate health index density predicts aggressive pathological outcomes after radical prostatectomy in Taiwanese patients
    74. 1.74
      MP002: Risk factors for acute urine retention after inguinal herniorrhaphy
    75. 1.75
      PD1-3: Surgery versus radiotherapy or radiotherapy with androgen deprivation therapy in the management of intermediate-risk or high-risk prostate cancer
    76. 1.76
      MP003: Thulium laser vaporesection of prostate versus bipolar versus monopolar transurethral resection of prostate in patients with benign prostatic obstruction: a retrospective study
    77. 1.77
      PD1-4: United in fight against prostate cancer registry (UFO): a post hoc analysis of secondary interim result in Taiwan
    78. 1.78
      MP004: Is renal cortex thickness correlated with blood loss during percutaneous nephrolithotomy?
    79. 1.79
      PD1-5: Combining prostate health index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population
    80. 1.80
      MP005: Outcome and possible complication of flexible ureteroscopy and laser lithotripsy for the ureteral stones and renal stones: a single center experience
    81. 1.81
      PD1-6: Real world experience of prostate health index in CMUH: its correlation with biopsy outcomes, and pathological stage after radical prostatectomy
    82. 1.82
      MP006: Retrospective comparison between coaxial metal dilatation and plasma vaporization for tract creation in percutaneous nephrolithotomy: a single center experience
    83. 1.83
      PD2-1: Robot-assisted and pure laparoscopic prostatectomy in high risk prostate cancer: TCVGH single team experience
    84. 1.84
      MP007: A bifid ureteral stone mimicking other abdominal calcification:a diagnostic pitfall
    85. 1.85
      PD2-2: Robotic-assisted radical cystectomy: experience of a single institution
    86. 1.86
      MP008: Operative outcomes of partial nephrectomy for renal angiomyolipoma : a comparision with robotic, laparoscopic and open partial nephrectomy
    87. 1.87
      PD2-3: Robotic radical cystectomy with intracorporeal neo-bladder reconstruction-CMUH experience
    88. 1.88
      MP009: Preliminary outcomes of laparoscopic partial thulium laser adrenalectomy in patient with small adrenal tumor
    89. 1.89
      PD2-4: Comparison of the surgical and functional outcomes for clinically benign versus malignant renal tumor after minimally invasive partial nephrectomy
    90. 1.90
      MP010: Trocar-less laparoscopy using nephroscope for placement of peritoneal dialysis catheters
    91. 1.91
      PD2-5: Laparoendoscopic single-site (LESS) nephroureterectomy, will robotic assist really help? a single hospital experience
    92. 1.92
      MP012: Tubeless Mini-Percutaneous nephrolithotomy versus retrograde intrarenal surgery for upper urinary stones of ≤ 3cm
    93. 1.93
      PD2-6: Robot-assisted radical cystectomy with neobladder reconstruction:single center experience and outcome
    94. 1.94
      MP013: Ureteral access sheath assisted straightening technique for kinking ureter during flexible ureteroscopy
    95. 1.95
      PD3-1: Cis-platinum induce PD-L1 expression through ERK/AP-1 signal cascade in bladder cancer cells
    96. 1.96
      MP014: Minipercutaneous nephrolithotomy for renal stones large than 5 cm
    97. 1.97
      PD3-2: Overexpression of SRC is associated with epithelial mesenchymal transition, invadopodia formation, drug resistant and stemness characters in urothelial carcinoma
    98. 1.98
      MP015: Urolithiasis is a risk factor for uroseptic shock and acute kidney injury in patients with urinary tract infection
    99. 1.99
      PD3-3: Miconazole, an anti-fungal agent, exerts bladder cancer chemoprevention by NRF2 activation
    100. 1.100
      MP016: The reason why patient return to emergency department following ureteroscopic lithotripsy
    101. 1.101
      PD3-4: Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan, direct comparison from Taiwan-Japan UTUC collaboration cohort.
    102. 1.102
      MP017: Effect of setting of shock wave delivery to stone disintegration in extracorporeal shock wave lithotripsy using solid coupling pad
    103. 1.103
      PD3-5: Prognostic value of USP2 overexpression in upper tract urothelial carcinomas in Taiwan.
    104. 1.104
      MP018: How the stone size can be performed with single access tract of percutaneous nephrolithotomy?
    105. 1.105
      PD3-6: The role of RENAL, PADUA, C-index, CSA nephrometry systems in predicting individual renal function after partial nephrectomy
    106. 1.106
      MP019: Pressure compression technique of the access tract with oxidized regenerated cellulose (surgicele) for tubeless mini-PCNL
    107. 1.107
      PD4-1: Identification, propagation and characterisation of circulating renal cancer stem cells
    108. 1.108
      MP020: Comparison of percutaneous nephrolithotomy with tubeless method and retrograde intrarenal surgery in kidney stone over 3cm
    109. 1.109
      PD4-2: Tumor-originated exosomal prothymosin-α triggers muscle wasting in bladder cancers
    110. 1.110
      MP021: Real world experience of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer
    111. 1.111
      PD4-3: Analysis of biochemical recurrence among pathology T2+ patients with prostate cancer
    112. 1.112
      MP022: Robotic radical prostatectomy for pathologic locally advanced prostate cancer, including pT3a, pT3b, pT4, and any TN1: single team experience
    113. 1.113
      PD4-4: Heteronemin exhibited cytotoxic effects in prostate cancer cells via oxidative and ER stress involved by protein tyrosine phosphatases activation
    114. 1.114
      MP023: Comparisons of robot assisted radical prostatectomy and high intensity focused ultrasound for the treatment of prostate cancer: single center experience
    115. 1.115
      PD4-5: Pathological staging prediction rate of mpMRI in prostate cancer- CMUH experience
    116. 1.116
      MP024: The treatment result of radium-223 on metastatic castration-resistant prostate cancer patients – experience in Taipei Veterans General Hospital
    117. 1.117
      PD4-6: Biopsy grade group 1: underestimation and outcomes after RaLRP
    118. 1.118
      MP025: Salvage high intensity focused ultrasound, cryoablation or radiotherapy after primary treatment of localized prostate cancer
    119. 1.119
      PD5-1: Using the novel “structural equation modeling” to analyze factors and pathways on the development of uric acid nephrolithiasis
    120. 1.120
      MP026: AICAR induces apoptosis and inhibits migration of prostate cancer cells through an AMPK/mTOR-dependent pathway
    121. 1.121
      PD5-2: Comparison of stone-free rate between percutaneous nephrolithotomy and retrograde intrarenal surgery
    122. 1.122
      MP027: Robotic partial nephrectomy for > 4cm renal cell carcinoma: single center experience
    123. 1.123
      PD5-3: Silodosin oral therapy facilitates stone clearance after shockwave lithotripsy for renal and ureteral calculi: a double-blind, randomized placebo-controlled study
    124. 1.124
      MP028: The efficacy of abiraterone and enzalutamide in a real life situation- the experience from Tung’s Taichung MetroHarbor Hospital
    125. 1.125
      PD5-4: How we make the retrograde intrarenal surgery an easier operation
    126. 1.126
      MP029: Radium-223 in the treatment of metastatic prostate cancer: preliminary experience in Taiwan
    127. 1.127
      PD5-5: The impact of climate factors on the prevalence of urolithiasis among patients with or without hyperuricemia
    128. 1.128
      MP030: Early dutasteride monotherapy in men with elevated serum prostate-specific antigen levels following robot-assisted radical prostatectomy
    129. 1.129
      PD5-6: Comparison of clear petra and navigator HD ureteral access sheath in retrograde intra-renal surgery: a single center experience
    130. 1.130
      MP031: Role of thrombospondin-4 (THBS4/TSP4) in bladder cancer cell invasion and its clinical application potential
    131. 1.131
      PD6-1: Dose testicular needle biopsy decrease the sperm retrieval rate in patients with non-obstructive azoospermia?
    132. 1.132
      MP032: Prothymosin-α enhances PTEN expression and binds with TRIM21 to regulate Keap1/Nrf2 signaling in human bladder cancer
    133. 1.133
      PD6-2: Hepatocyte nuclear factor 4 alpha P2 promoter variants associate with the risk of metabolic syndrome and testosterone deficiency in aging Taiwanese men
    134. 1.134
      MP033: MiR-30a-3p inhibits bladder cancer autophagy and invasion by suppressing autophagic genes and matrix metalloproteinases expression
    135. 1.135
      PD6-3: The outcome of transurethral seminal vesiculoscopy for diagnosis and treatment of hemospermia, and a case report of amyloidosis of seminal vesicle
    136. 1.136
      MP034: Comparison between complete response of trimodality therapy and neoadjuvant chemotherapy with radical cystectomy in muscle invasive bladder cancer - CMUH experience
    137. 1.137
      PD6-4: The role of coenzyme Q10 on the reproductive function of male mice model of chronic kidney disease
    138. 1.138
      MP035: Deduction of genes potentially involving in urothelial carcinoma apoptosis by EGCG using next-generation sequencing and bioinformatics approaches
    139. 1.139
      PD6-5: Testis-specific SEPT12 expression affects SUN protein localization and is involved in mammalian spermiogenesis
    140. 1.140
      MP036: Benzyl isothiocyanate increases expression of miR-99a, a well-characterized tumor suppressor gene, in bladder cancer through ERK/AP-1 signal pathway
    141. 1.141
      PD6-6: The impact of erectile function in male overactive bladder patients treated with Mirabegron
    142. 1.142
      MP037: Synergistic effect of histone deacetylase inhibitors in intravesical instillation of bladder cancer: preliminary results of molecular mechanism and animal model
    143. 1.143
      PD7-2: Effects of low intensity extracorporeal shockwave therapy (LESWT) on inflammatory mediators and central sensitization on capsaicin induced nonbacterial prostatitis model in rats
    144. 1.144
      MP038: Comparisons of robot-assisted partial nephrectomy and laparoscopic cryoablation for the treatment of localized renal tumor
    145. 1.145
      PD7-1: Ketamine-induced bladder dysfunction is associated with extracellular matrix accumulation and impairment of calcium signaling in a mouse model
    146. 1.146
      MP039: The prognostic significance of TNFAIP6 overexpression in patients with urothelial carcinoma
    147. 1.147
      PD7-3: The impact of pseudoephedrine and antihistamine on male lower urinary tract symptoms
    148. 1.148
      MP040: T1 substage in superficial bladder urothelial carcinoma can predict progression free survival
    149. 1.149
      PD7-4: The degree of intravesical prostatic protrusion can predict the treatment response for male overactive bladder patients treated with Mirabegron
    150. 1.150
      MP041: Factors associated with urinary tract infection in patients with chronic spinal cord injury
    151. 1.151
      PD7-5: Is low- intensity extracorporeal shockwave therapy still effective for patients with chronic pelvic pain syndrome in the long term? A 12 month follow-up
    152. 1.152
      MP042: The long term efficacy between women with pelvic floor dysfunction received retropubic suburethral sling with or without concomitant POP repair
    153. 1.153
      PD7-6: Is intravesical prostatic protrusion (IPP) a reliable predictor of overactive bladder in male patients with lower urinary tract symptoms (LUTS) ?
    154. 1.154
      MP043: Retrospective review on trans-obturator tension-free vaginal tape (TVT-O) for stress urinary incontinence: 3-year experience of a single center.
    155. 1.155
      PD8-1: Tadalafil can ameliorate bladder overactivity through rescuing insulin-activated detrusor relaxation via bladder mucosal IRS/PI3K/AKT/eNOS pathway in a rat model of metabolic syndrome
    156. 1.156
      MP044: Is extent of infected area or the numbers of bacterial strains from wound culture can be the indicator of duration of admission on patients with Fournier’s gangrene?
    157. 1.157
      PD8-2: Stress receptor, neurotrophin and cell regeneration markers expression in the urothelium of detrusor overactivity, detrusor underactivity and detrusor hyperreflexia with inadequate contractility.
    158. 1.158
      MP045: The meaning of pyuria in female midstream urine analysis
    159. 1.159
      PD8-3: Does urodynamic study have benefit in patients with acute urinary retention?
    160. 1.160
      MP046: Ketamine ameliorates the social stress related bladder dysfunction in mice
    161. 1.161
      PD8-5: Outcomes of urethroplasty for anterior urethral strictures:single-center experience
    162. 1.162
      MP047: Effect of intraoperative hypothermia on renal function during cadaveric renal transplantation
    163. 1.163
      PD8-6: Regular cystoscopy-assisted bladder toilet is beneficial in catheter-associated urinary tract infection
    164. 1.164
      MP048: Early endoscopic realignment for traumatic urethral total disruption- CMUH experience
    165. 1.165
      PD9-1: Clinical outcome of dismembered pyeloplasty in the treatment of non-symptomatic ureteropelvic junction obstruction
    166. 1.166
      MP049: Oncologic outcomes of partial cystectomy compared to radical cystectomy for muscle invasive bladder cancer
    167. 1.167
      PD9-2: Investigation of interactive activity of electro-acupuncture on pharmacokinetics of sildenafil and their synergistic effect on penile blood flow in rats
    168. 1.168
      MP050: Intravesical recurrence rate of diagnostic ureteroscopy prior to nephroureterectomy for upper tract urothelial carcinoma
    169. 1.169
      PD9-3: Neuronal nitric oxide synthase activity mediates lycium barbarum polysaccharides-enhanced sexual performance
    170. 1.170
      MP051: Hormone-secreting adrenocortical carcinoma: a case report
    171. 1.171
      PD9-4: The potential effect of different doses of ionizing radiation on genes and disease
    172. 1.172
      MP052: MicroRNA-145 regulates invasion in upper tract urothelial carcinoma by targeting ARF6
    173. 1.173
      PD9-5: Testing the text mining analysis on large amount literature from PubMed to describe current medical scientific research trends
    174. 1.174
      MP053: Renal cell carcinoma T3 stages subgroup survival analysis - a retrospective single-institution study
    175. 1.175
      PD9-6: ABO-incompatible living related donor renal transplantations: experience from China Medical University Hospital
    176. 1.176
      MP054: Tumor contact surface area predict the non-tumor renal volume after partial nephrectomy
    177. 1.177
      MP055: Clinicopathologic analysis of epithelioid renal angiomyolipoma: a single institute experience of consecutively excised 23 cases
    178. 1.178
      MP056: Prognostic factors for patients with de novo metastatic renal cell carcinoma receiving cytoreductive nephrectomy followed with target therapy: who will really benefit from the cytoreductive nephrectomy?
    179. 1.179
      MP057: Elucidation of the therapeutic role of osmanthus fragrans active compound in the regulation of prostate cancer
    180. 1.180
      MP058: Gold nanoparticle as photosensitizing agent in photodynamic therapy targeting bladder cancer
    181. 1.181
      MP059: The clinical significance of tumor size and preoperative systemic immune-inflammation index (SII) in oncologic outcomes in patients with upper tract urothelial carcinomas (UTUC)
    182. 1.182
      MP060: Outcome of lymph node dissection in renal pelvis urothelial carcinoma
    183. 1.183
      MP061: The relationship of prostate health index (PHI) and PSA based on the age group in CMUH experience
    184. 1.184
      MP062: Elucidation of the therapeutic role of nuclear respiratory factor-1 in the regulation of prostate cancer
    185. 1.185
      MP063: Prostate-specific antigen testing related to rising incidence of prostate cancer
    186. 1.186
      MP064: Association of prostate cancer with 5-alpha reductase as Finasteride and Dutasteride.
    187. 1.187
      MP065: The association between androgen deprivation therapy and the risk of tenosynovitis
    188. 1.188
      MP066: Infection after transrectal ultrasound-guided prostate biopsy - rate and contributing factors at a regional hospital
    189. 1.189
      MP067: Outcomes of robot-assisted radical prostatectomy in men with previous transurethral resection of prostate
    190. 1.190
      MP068: Intravesical hyaluronic acid instillation in the treatment of radiation-induced hemorrhagic cystitis in Taipei city hospital experience
    191. 1.191
      MP069: The results of combined radiation therapy and hormonal therapy in the treatment of lymph node-positive prostate cancer: experience of a single institution
    192. 1.192
      MP070: Identification of urothelial cancer mutations by targeted deep sequencing of plasma DNA
    193. 1.193
      MP071: The association of dysregulated methylation of BOLL promoter in human spermatogenesis
    194. 1.194
      MP072: Investigating the downstream candidate genes after hypermethylation of the MAEL promoter region in targeted DNA methylation(TDM) cell model
    195. 1.195
      MP074: Sperm retrieval outcome of infertile men with previous episode of mumps orchitis.
    196. 1.196
      MP075: The cost-effectiveness of Y chromosome microdeletion testing in men with severe oligozoospermia
    197. 1.197
      MP076: The experience of vassal sperm aspiration on patients with an-ejaculation or retrograde ejaculation
    198. 1.198
      MP077: How long does the effect last of low intensity shock wave treatment (LISWT) for erectile dysfunction (ED)? A prospective study with an average 8 months follow-up
    199. 1.199
      MP078: Sedentary workload has negative impacts on male erectile and lower urinary tract function
    200. 1.200
      MP079: Is early realignment of urethra injury in pelvic fracture associated with lower urethra stricture rate? An Asian population study in Taiwan
    201. 1.201
      MP080: The risk factors of hyponatremia in the desmopressin replacement of elderly patients with nocturnal polyuria
    202. 1.202
      MP081: Long-term statins use reduces risk of bladder cancer in hyperlipidemia women: a population-based study
    203. 1.203
      MP082: Continuous bladder irrigation with distilled water following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with normal saline
    204. 1.204
      MP083: An immune checkpoint inhibitor as neoadjuvant therapy in patients with bladder urothelial carcinoma: preliminary experiences in a single institute
    205. 1.205
      MP084: Oncologic outcomes of kidney sparing surgery using endoscopic management compared with radical nephroureterectomy in upper urinary tract urothelial carcinoma
    206. 1.206
      MP085: The impact of preoperative renal function and neutrophil to lymphocyte ratio on intra-vesical recurrence in patients with upper tract urothelial carcinomas (UTUC) after radical nephroureterectomy (RNU)
    207. 1.207
      MP086: Systemic immune-inflammation index can predicts prognosis in patients of localized upper tract urothelial carcinoma treated with laparoscopic radical nephroureterectomy with bladder cuff excision
    208. 1.208
      MP087: Outcomes of laparoscopic and robotic nephroureterectomy approaches in patients with T3 and T4 upper tract urothelial carcinoma in CMUH
    209. 1.209
      MP088: Ingle-docking robotic-assisted nephroureterectomy with bladder cuff excision on Da Vinci Si system with arm and instrument switching
    210. 1.210
      MP089: Relationship between native hydronephrosis and upper tract urothelial carcinoma after kidney transplantation
    211. 1.211
      MP090: Predictors of intravesical recurrence after radical nephroureterectomy and prognosis in patients with upper tract urothelial carcinoma
    212. 1.212
      MP091: Immunotherapy of urological cancer in single center experience: advances and challenges
    213. 1.213
      MP092: Programmed death-ligand 1 in upper urinary tract carcinoma
    214. 1.214
      MP093: Association of bladder mitomycin-C instillation during robotic nephroureterectomy with bladder cuff excision with bladder recurrence.
    215. 1.215
      MP094: The oncologic benefit of maximal transurethral resection of bladder cancer in muscle invasive bladder tumor
    216. 1.216
      MP095: Single-docking robotic nephroureterectomy for upper tract urothelial carcinoma : preliminary results
    217. 1.217
      MP096: Two-stage multiple-tract minipercutaneous nephrolithotomy for the treatment of complete staghorn stones: a case experience
    218. 1.218
      MP097: Short-term prognosis of immediate transurethral surgery for benign prostate obstruction with acute urinary retention episode
    219. 1.219
      MP098: Different laparoscopic partial cystectomy approach for bladder leiomyoma
    220. 1.220
      MP099: Ureteral reconstruction for patient with ureteral stricture in more challenging situations
    221. 1.221
      MP100: Thulium laser treatment for large prostate (80 gm)- CMUH experience
地址：台北市 11051 信義區基隆路一段432號6樓之1, 電話：02-2729-0819, 傳真：02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw